|
ZNF254 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.949430E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.892300E-02 |
| Normal-vs-Stage2 |
9.758400E-01 |
| Normal-vs-Stage3 |
2.350800E-01 |
| Normal-vs-Stage4 |
4.904100E-02 |
| Stage1-vs-Stage2 |
3.444800E-01 |
| Stage1-vs-Stage3 |
9.264200E-01 |
| Stage1-vs-Stage4 |
3.721600E-01 |
| Stage2-vs-Stage3 |
4.203800E-01 |
| Stage2-vs-Stage4 |
2.300400E-01 |
| Stage3-vs-Stage4 |
4.551000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.586220E-01 |
| Normal-vs-AfricanAmerican |
2.997800E-01 |
| Normal-vs-Asian |
6.791800E-01 |
| Caucasian-vs-AfricanAmerican |
7.254800E-01 |
| Caucasian-vs-Asian |
7.613600E-01 |
| AfricanAmerican-vs-Asian |
8.795200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.996300E-02 |
| Normal-vs-Female |
8.194400E-01 |
| Male-vs-Female |
7.007800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.482820E-01 |
| Normal-vs-Extreme_Weight |
5.743600E-02 |
| Normal-vs-Obese |
3.915400E-01 |
| Normal-vs-Extreme_Obese |
2.564600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.764600E-01 |
| Normal_Weight-vs-Obese |
5.053800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.922800E-01 |
| Extreme_Weight-vs-Obese |
2.622400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.748000E-01 |
| Obese-vs-Extreme_Obese |
6.823800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.125600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.076400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.366000E-02 |
| Normal-vs-Age(81-100Yrs) |
6.002300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.962000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.745800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.392470E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.006240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.696000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.059400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.285000E-01 |
| Normal-VS-Type2 PRCC |
8.516700E-03 |
| Normal-VS-KIRP CIMP |
1.141040E-01 |
| Normal-VS-Unclassified PRCC |
5.363200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.939660E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.241800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.116400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.773000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.223600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.182000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.104040E-02 |
| Normal-vs-N1 |
9.991600E-01 |
| Normal-vs-N2 |
1.930480E-02 |
| N0-vs-N1 |
1.031550E-01 |
| N0-vs-N2 |
1.558600E-01 |
| N1-vs-N2 |
1.185950E-01 |
|
|
